NCT00508040View on ClinicalTrials.gov

Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

January 31, 2013

Conditions
Birdshot ChorioretinopathyCystoid Macular EdemaTransient Partial Visual Loss
Interventions
DRUG

interferon alpha 2a

We propose to analyse the potential therapeutic effect of Interferon alpha2 a versus Steroid therapy with a control group for a 4 months period. This short period could not expose to a worsening of the disease because of the slow pathologic processus.

DRUG

prednisone

We propose to analyse the potential therapeutic effect of Interferon alpha2 a versus Steroid therapy with a control group for a 4 months period. This short period could not expose to a worsening of the disease because of the slow pathologic processus.

Trial Locations (1)

75013

Hopital La Pitie Salpetriere, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00508040 - Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a | Biotech Hunter | Biotech Hunter